Publication | Closed Access

The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation

Nsclc TumorigenesisSignal TransductionSignaling PathwayChemoprevention StrategyHippo SignalingMedicineTumor SuppressorRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor BiologyYap Nuclear Translocation